- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01599845
The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers (Nanoexposure)
The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers (Nanoexposure)
Study Overview
Status
Conditions
Detailed Description
This study investigates the following questions:
Does occupational exposure to nanoparticles influence permeation of such particles to respiratory airways? Is there a correlation between the levels of nanoparticles in sample biological fluids of the patients and their pulmonary functions.
Is there a correlation between the levels of nanoparticles in sample biological fluids of the patients and respiratory tract infections.
The study protocol includes the following steps:
Initial interview of the patient Measurement of nanoparticles in samples of exhaled breath condensate using NanoSight LM 20 Measurement of nanoparticles in induced sputum. And finally examination of the relationship between the measured parameters and the indices of pulmonary infection, and pulmonary function as measured by the pulmonary department of the TASMC.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Yehuda Schwarz, M.D.
- Phone Number: 03-6973774
- Email: schwarz.reot@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults over 20 years of age who visit Ichilov Hospital for medical complaints/inquiries regarding respiratory tract.
- Study population is composed of people who are exposed to environmental particles form industrial sources.
- Informed consent is requested from each subject.
Exclusion Criteria:
- Unemployed individuals.
- Individuals who are not working in industrial jobs, such as office workers and secretaries.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Nanoparticle exposed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analysis of the size distribution of nano-particles in exhaled breath condensate
Time Frame: One year
|
Each subject will be examined once.
The total time for collection of data is estimated as about one year.
|
One year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yehuda Schwarz, M.D., Tel Aviv Sourasky Medical Center (TASMC, Ichilov)
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TASMC-11-YS-0107-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inadequate or Impaired Respiratory Function
-
Universidade Metodista de PiracicabaCompletedInadequate or Impaired Respiratory FunctionBrazil
-
University of DebrecenCompletedPain | Inadequate or Impaired Respiratory FunctionHungary
-
Universidade Metodista de PiracicabaCompletedHypertension | Diabetes | Inadequate or Impaired Respiratory FunctionBrazil
-
Jawaharlal Institute of Postgraduate Medical Education...CompletedPain, Postoperative | Stress Response | Inadequate or Impaired Respiratory Function | Analgesic Requirement | Return of Bowel ActivityIndia
-
University of PadovaCompletedInadequate or Impaired Breathing Pattern or VentilationItaly
-
Boston Children's HospitalWithdrawnInadequate; Pulmonary Function, Newborn
-
Prince of Songkla UniversityUnknownInadequate or Impaired Breathing Pattern or VentilationThailand
-
Prince of Songkla UniversityMcGill University Health Centre/Research Institute of the McGill University...CompletedDifficult Intubation | Anesthesia; Adverse Effect | Inadequate or Impaired Breathing Pattern or VentilationThailand
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionUnited States
-
Novartis PharmaceuticalsCompletedNormal Hepatic Function | Impaired Hepatic FunctionBelgium, Germany, Israel, Bulgaria, United States